Evidence map›Paper›PMID 34053449›Full record

ArticleBMC microbiology2021

Abundance alteration of nondominant species in fecal-associated microbiome of patients with SAPHO syndrome.

Jianhua Zhen, Yuxiu Sun, Pengfei Zhao, Chen Li, Hesong Wang, Yini Li, Lu Zhao, Li Wang, Guangrui Huang, Anlong Xu

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jianhua Zhen *School of Life Sciences, Beijing University of Chinese Medicine, Beijing, 100029, China.
Yuxiu Sun *School of Life Sciences, Beijing University of Chinese Medicine, Beijing, 100029, China.
Pengfei Zhao *School of Life Sciences, Beijing University of Chinese Medicine, Beijing, 100029, China.
Chen Li *Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, Beijing, 100730, China.
Hesong Wang *School of Life Sciences, Beijing University of Chinese Medicine, Beijing, 100029, China.
Yini LiSchool of Life Sciences, Beijing University of Chinese Medicine, Beijing, 100029, China.
Lu ZhaoSchool of Life Sciences, Beijing University of Chinese Medicine, Beijing, 100029, China.
Li WangInstitute of Biology, Henan Academy of Sciences, Zhengzhou, 450008, Henan, China.
Guangrui HuangSchool of Life Sciences, Beijing University of Chinese Medicine, Beijing, 100029, China. hgr@bucm.edu.cn.ORCID 0000-0003-1846-0227
Anlong XuSchool of Life Sciences, Beijing University of Chinese Medicine, Beijing, 100029, China. xuanlong@bucm.edu.cn.
Beijing University of Chinese Medicine · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNHenan Academy of Sciences · CN

Funding

International Science & Technology Cooperation Program of China 2014DFA32950National Key Research and Development Program of China 2016YFC0901500National Natural Science Foundation of China 31500704National Natural Science Foundation of China 81430099Research Program From Beijing University of Chinese Medicine 1000041510049Research Program From Beijing University of Chinese Medicine 2019-JYB-TD013Research Program From Beijing University of Chinese Medicine BUCM-2019-JCRC006the CAMS Initiative for Innovative Medicine 2017-I2M-3-001the Capital Medical Research and Development Fund 2016-4-40112
6 · The paper itself

Abstract

backgroundSAPHO syndrome is a group of symptoms consisting of synovitis, acne, pustulosis, hyperostosis and osteosis. There is no specific laboratory index assist in the diagnosis of SAPHO because of its highly heterogeneous clinical manifestations. Pathogenic microorganisms had been identified in biopsies of some SAPHO cases and particular gene mutations were also linked to the occurrence of SAPHO. It is largely unknown whether intestinal microbiome plays a role in pathogenesis of SAPHO. To explore the intestinal microbiome structure of SAPHO syndrome, fecal samples from 17 SAPHO patients and 14 healthy controls (HC) were collected for 16S rDNA sequencing.

resultsOur results showed that there was no significant difference in alpha indexes and beta diversity between SAPHO and HC samples, while there were 14 operational taxonomic units (OTUs) in the Wilcoxon rank-sum test and 42 OTUs in the MetagenomeSeq analysis showed significant difference in distribution between the SAPHO and HC groups, 3 of which in Firmicutes were also observed in the random forest analysis and used to construct a receiver operating characteristic curve to evaluate the diagnostic value, the area under the curve was 0.86.

conclusionFecal-associated microbiome in the SAPHO samples was characterized by the alteration in abundance of some nondominant species, and the 3 selected OTUs in Firmicutes could serve as candidate biomarkers for SAPHO syndrome diagnosis.

Indexed as

Gastrointestinal MicrobiomeAcquired Hyperostosis SyndromeAdultBacteriaFecesFemaleHumansMaleMiddle AgedYoung AdultBiomarkersFecal-associated microbiomeSAPHO syndrome

Identifiers

PMID34053449
PMCPMC8166064
OpenAlexW3164089111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.